SCHEMBL3600784

SCHEMBL3600784

O=C(Cn1ccc2ccc(-c3cccc(F)c3)cc21)NCCNCC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 13/20 0.48
PIM1 P11309 1/20 0.45
PIM2 Q9P1W9 1/20 0.45
NPY5R Q15761 1/20 0.44
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 2/20 0.42
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ICMT O60725 1/20 0.40
NTSR1 P30989 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3600291 0.92 GRIN2B (0.55) GRIN2BNPY5RKDM4EALDH1A1TSHR
SCHEMBL3598451 0.91 ALDH1A1 (0.45) GRIN2BKDM4EALDH1A1TSHRHSD17B10
SCHEMBL3600906 0.89 GRIN2B (0.47) GRIN2BKDM4EALDH1A1TSHRHSD17B10
SCHEMBL3596849 0.88 GRIN2B (0.43) GRIN2BPIM1PIM2NPY5RKDM4E
SCHEMBL3603618 0.87 OPRM1 (0.44) GRIN2BNPY5RKDM4EALDH1A1TSHR
SCHEMBL3592474 0.86 KDM4E (0.46) KDM4EALDH1A1TSHRHSD17B10HPGD
SCHEMBL3602556 0.86 ALDH1A1 (0.55) GRIN2BNPY5RKDM4EALDH1A1TSHR
SCHEMBL3592867 0.86 GRIN2B (0.50) GRIN2BNPY5RKDM4EALDH1A1HPGD
SCHEMBL3602467 0.86 KDM4E (0.46) GRIN2BNPY5RKDM4EALDH1A1TSHR
SCHEMBL3597368 0.86 TSHR (0.46) GRIN2BNPY5RKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 GRIN2B 2950/4885PIM1 592/4885PIM2 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.